35
Infection and replication of HCV in B cells is not uncommon in HCV-infected patients 12 . In fact, HCV 36 has been detected in patient-derived B cells 13 . Therefore, HCV naturally infects B cells. In addition, HCV 37 infection of human T cells has also been documented. To develop an HCV infection system in primary T cells 38 and T cell lines, immune activation is required to upregulate the susceptibility of cells to both HCV infection and 39 expression in infected cells 14, 15 . The mechanism by which B7. 
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HCV clone
termed SB-HCV17. Using 14 overlapping cDNA clones derived from SB cells, we constructed a plasmid 1 containing the complete genome sequence of SB-HCV (pHCVSB2b). All amplified products were purified and 2 then cloned into pGEM-T EASY vectors (Promega, Madison, WI), resulting in 14 plasmids, including pGEM1-
20
To generate pSB/JFH1/GND chimera virus construct carrying a mutation in the NS5B GDD motif, which
21
abolishes RNA polymerase activity, amino acid substitutions will be introduced by PCR-based site-directed mutagenesis in (MLVCGDDLVV) encompassing the GDD motif of NS5B, and amplified DNA fragments will be
23
analyzed by automated nucleotide sequencing by using an ABI 310 sequencer. GDD motif will be changed into
24
GND.
26
Infection of cells with secreted HCV
27
JFH-1 strain, SB strain from SB cells (spleen B cells), and SB/JFH1 chimera virus were used for in vitro 28 infection studies 18, 22 . Genotype 1a/1b hybrid strain was previously described 23 . Concentrated culture medium
29
(100 μl) was used for inoculation of cells in a well of 12-or 6-well plate for 3 h with periodic rocking. At the end
30
of inoculation, cells were washed 3 times with PBS, followed by addition of 1 or 2 ml of complete culture 31 medium. At six days after infection, inoculated cells were fixed and subsequently stained using anti-NS3
32
antibodies. Positively stained cells were counted in a blinded fashion. HCV RNA titer was reduced by prior 33 treatment with anti-E2 antibody. The titer of JFH1 viral stock was determined as previously described 22 .
35
Real 
40
The real time PCR signals were analyzed using SDS software (Version 2.1; Applied Biosystems). For miR-122 expression analysis, RNA was reversed transcribed by High-Capacity cDNA synthesis Kit (Applied Biosystems)
42
and normalized by U6 RNA levels as previously described 24 .
44
Negative strand detection of HCV
45
Negative strand-specific SB-HCV RNA was detected by using of a nested PCR method using 4-fold 46 serial dilution of RNA by using a recently established procedure previously described [25] [26] [27] . Viral RNA was 47 purified with QIAmp Viral RNA Minikit (Qiagen). Negative strand-specific SB-HCV RNA were detected by use 48 of a nested polymerase chain reaction (PCR) method
RNA transfection
synthesized RNA was used for electroporation as previously described 22 . 29, 30 , plasmids expressing the viral glycoproteins
55
10
(pCMV-HCV E1E2p7 or pCMV-HCV E1E2), including SB (genotype 2b), N (N E1E2), and strain Con1 HCV
11
E1E2 gps or an empty vector. All virus stocks were normalized for p24 HIV core antigen and infected at 1 ng
12
per well, with the exception of VSV gp and MLV gp, which was used at 0.01 ng per well. Positive control 13 pseudo-particles were generated without glycoproteins and with the VSV-G (pMD.G) 29 
30
Persistent HCV infection of humanized mouse model
31
To further study the generality of the HCV infection of human immune systems, we developed a mouse 
50
Exosome Isolation
51
Exosome was isolated from plasma from HCV patients and healthy individuals by ExoQuick exosome 52 precipitation solution and centrifuged at 1,500g for 30 minutes from 100 μl of plasma after incubation at 4°C for committee approval was obtained in University of Southern California. The supernatant was denoted the 1 protein-rich fraction, whereas the pellet was denoted the exosome-rich fraction. The pellet (the exosome-rich 2 fraction) was washed twice with phosphate-buffered saline (PBS) and lysed with QIAzole (Qiagen) or lysed 3 with TRI reagent for total RNA or protein isolation. As the exosome precipitation solution precipitates up to 90 4 nm size particles, microparticles (≈200-1,000 nm) is in protein-rich fraction.
6
Plasma MicroRNA Analysis 
11
of plasma or serum samples were thawed on ice, plasma miR was isolated as previously described 33,34 using
12
TRI reagent and measured by TaqMan miRNA Assay (Applied Biosystems). Synthetic U6 RNA or
13
Caenorhabditis elegans (cel)-miR-39 was spiked and after this step miRNeasy kit protocol was followed as per 14 instructions (Qiagen). Cel-miR-39 was used to normalize the technical variation between the samples.
16
Coreceptor cloning by lentivirus Raji cell cDNA library screen in HEK293T cells
17
To identify the possible novel receptor specific for the infection of lymphotropic HCV, We performed a lentivirus 
36
E2 binding assays
37
Binding of E2 to cell surface via B7.2 was analyzed by a fluorescence-activated cell sorting (FACS)-38 based assay as previously described 35, 36 . 
48
Calcium mobilization assay
49
Calcium mobilization assay was performed as previously described Annexin V apoptosis assay was performed as previously described 6 . The cells were fixed in cold 70% ethanol 1 (0.5 ml) at 4 °C for 1 h. Memory B cells (2 × 10 6 ) were incubated with 1 μg/mL FLAG-tagged CD40L, 6 U/mL 2 IL-2 (R&D Systems) and 200 ng/mL IL-10 (R&D Systems) with 2 μg/mL mouse IgG 1 anti-FLAG antibody 3 (Alexis Biochemicals) in RPMI/10% fetal calf serum at 37°C for 0 and 6 hours and were washed with PBS and 4 resuspended. After incubation with annexin V-phycoerythrin at r.t., cells were stained with anti-CD27 FITC at 5 r.t. Flow cytometry was performed. Ratio of apoptosis was examined by a FACScan data acquisition for red 6 fluorescence.
8 9
The secretion of IgM isotypes
To test whether binding by HCV to B7.2 can downregulates B7.2-induced signaling pathways,
11
immunoglobulin secretion assays were performed as previously described 6 . Resting B cells (50,000/well in 96-
12
well round-bottom plates) were were purified from PBMC by negative selection and cultured for 6 days with 1
13
μg/mL FLAG-tagged CD40L, 6 U/mL IL-2 (R&D Systems) and 200 ng/mL IL-10 (R&D Systems) with 2 μg/mL 
21
(Jackson ImmunoResearch Laboratories), and incubated at 37°C for 6 hours. Plates were then incubated with horseradish peroxidase-labeled anti-human IgM, and the assays were developed with 3-amino-9-
23
ethylcarbazole (Sigma-Aldrich) and spots were counted. For ELISA, the supernatants were collected on day 6
24
and analyzed for IgM by enzyme-linked immunosorbent assay 37 . Briefly, wells were coated overnight at 4 °C
25
with 5 μg/ml goat anti-mouse IgM Abs in carbonate-bicarbonate buffer, pH 9.6. The unbound sites were
26
blocked with 2% BSA, and then culture supernatants were added for 2 h at 37 °C and incubated with rabbit 
33 34
Statistical analysis
35
ANOVA analysis was used for multiple comparisons. Pearson's correlation test was performed for correlation
